Separation and extraction method of placenta amniotic mesenchymal stem cells and application of placenta amniotic mesenchymal stem cells in postpartum recovery

Through the treatment of placenta amniotic membrane and the use of specific culture media, the problems of low separation efficiency and complex operation of placenta amniotic mesenchymal stem cells are solved, and high purity cells are obtained, suitable for postpartum recovery and have high proliferation and differentiation capabilities.

CN118995590APending Publication Date: 2024-11-22GUANGDONG CELL BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411141998.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the prior art, the isolation and preparation of placenta amniotic mesenchymal stem cells have problems such as low separation efficiency, complex operation and high cost.

Method used

A method that involves the following steps: peel off and wash the amniotic membrane of the placenta, add type I and II collagenase, phosphate buffer, and then add collagenase I and DNase I for shock digestion, obtain cells by centrifugation, and put them into It is cultured in a suitable culture medium.

Benefits of technology

High-purity placental amniotic mesenchymal stem cells are achieved in the case of rapid and minor damage to stem cells, with high proliferation and differentiation capabilities, and are suitable for postpartum recovery.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention provides a placenta amniotic mesenchymal stem cell separation and extraction method and application thereof in postpartum recovery, the extraction method comprises the following steps: (1) placing a placenta in a treatment disc, stripping an amniotic membrane from the placenta along the joint of an umbilical cord and the placenta, and cleaning; (2) putting the cleaned amniotic membrane tissue into a test tube, adding a mixture consisting of type I collagenase, type II collagenase and a phosphate buffer solution, and treating; (3) continuing to add collagenase I, DNase I and normal saline into the treated amniotic membrane tissue, and digesting; (4) after vibration digestion, centrifuging, and discarding supernatant to obtain centrifuged cells; and (5) adding the centrifuged cells into a fresh culture medium, and culturing in a CO2 incubator. According to the extraction method and the special culture medium for extraction provided by the invention, the placenta amniotic mesenchymal stem cells can be rapidly obtained under the condition of relatively small damage to the stem cells. The stem cells are high in purity, have high proliferation and differentiation capacity and can be applied to postpartum recovery.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and in particular relates to a method for separating and extracting placental amniotic mesenchymal stem cells and an application thereof in postpartum recovery. Background Art

[0002] Mesenchymal Stem Cells (MSCs) are a type of adult stem cells with multidirectional differentiation potential and self-renewal ability. These cells can differentiate into a variety of mesoderm-derived cell types, including but not limited to osteocytes, chondrocytes, adipocytes, muscle cells, and fibroblasts. In addition, mesenchymal stem cells also show the potential to differentiate into non-mesoderm-derived cell types, such as neuron-like cells. The main characteristics of mesenchymal stem cells include: Self-renewal ability: able to be cultured in vitro for a long time and remain undifferentiated. Multidirectional differentiation potential: under appropriate conditions, they can differentiate into a variety of cell types.

[0003] Immunomodulatory function: It has immunosuppressive properties and can affect the functions of various immune cells, including T cells, B cells, natural killer cells and antigen presenting cells. Homing and migration ability: It can migrate to the site of injury or inflammation in the body and participate in tissue repair and regeneration. The sources of mesenchymal stem cells are diverse, including but not limited to: Bone marrow: The most classic source, but the extraction process is relatively invasive. Adipose tissue: It is relatively easy to obtain and contains rich mesenchymal stem cells. Umbilical cord and placental tissue: It can be collected after the birth of the newborn, avoiding ethical disputes, and the cells are young and active. Dental pulp, skin, muscle and other connective tissues: Mesenchymal stem cells from these sources are also being explored in research. Mesenchymal stem cells are widely used in clinical and research, including: Tissue engineering and regenerative medicine: used to repair damaged tissues and organs. Treatment of immune and inflammatory diseases: Use its immunomodulatory effects to treat autoimmune diseases and inflammation. Cardiovascular disease: Used for heart repair after myocardial infarction. Neurological diseases: Such as the treatment of Parkinson's disease, Alzheimer's disease and spinal cord injury. Metabolic diseases: such as the treatment of diabetes, by differentiation into pancreatic islet cells. Beauty and skin repair: for skin regeneration and anti-aging.

[0004] Placental amniotic mesenchymal stem cells (AMSCs) are a type of stem cell isolated from the amniotic membrane of the placenta. These stem cells have a variety of biological properties, including multidirectional differentiation potential, immunomodulatory ability, and self-renewal ability. They can differentiate into a variety of different cell types and can secrete a variety of growth factors and cytokines, which makes them potentially useful in the field of tissue repair and regenerative medicine.

[0005] Mesenchymal stem cells can differentiate into various types of cells, including epithelial cells, muscle cells, and nerve cells, thus contributing to the repair and regeneration of damaged tissues. They have immunomodulatory properties, can inhibit inflammatory responses, reduce postpartum inflammation, and promote the healing process. Factors secreted by stem cells can stimulate angiogenesis, improve local blood circulation, and accelerate tissue repair. Studies have shown that mesenchymal stem cell transplantation can increase the thickness of the endometrium, reduce fibrosis, and increase the number of glands, which is of great significance for the recovery of the endometrium after childbirth.

[0006] However, the existing technology for the separation and preparation of placental amniotic mesenchymal stem cells has the problems of low separation efficiency, complex operation and high cost. Summary of the invention

[0007] The purpose of the present invention is to provide a method for separating and extracting placental amniotic mesenchymal stem cells and application thereof in postpartum recovery.

[0008] In order to achieve the above object, the present invention provides the following technical solutions: A method for separating and extracting placental amniotic mesenchymal stem cells comprises the following steps: (1) Place the placenta in a processing tray, peel off the amniotic membrane from the placenta along the connection between the umbilical cord and the placenta, wash it with cleaning solution 2-4 times, and then rinse it with 75% alcohol by volume 2-4 times; (2) Cut the rinsed amniotic membrane into pieces of 1-2 cm 2 The amniotic tissue is washed with a cleaning solution for 2-3 times, and the washed amniotic tissue is placed in a test tube and a mixture of type I and II collagenase and phosphate buffer is added, and the mixture is treated at 35-36°C for 30-40 minutes; (3) Continue to wash the treated amniotic tissue with cleaning solution for 2-4 times, add collagenase I, DNase I and normal saline, and digest at 35-36°C and 160-180 rpm for 30-40 minutes; (4) After shaking digestion, add physiological saline, centrifuge at 1400-1500 rpm at 35-36°C for 5-10 minutes, discard the supernatant, and obtain the centrifuged cells; (5) Add the centrifuged cells to fresh culture medium and culture them in a CO2 incubator.

[0009] Furthermore, in step (2), the mass ratio of type I collagenase to type II collagenase is 1:1.2-1.7.

[0010] Furthermore, in step (2), 1 mL of a mixture of type I and II collagenase and phosphate buffer is used per gram of adipose tissue, and the treatment time is 1-1.5 hours.

[0011] Furthermore, in step (3), the concentration of collagenase I in the centrifuge tube is 0.1wt%, and the concentration of DNase I is 0.02wt%.

[0012] Furthermore, the fresh culture medium in step (5) consists of a basal culture medium and additional components added to the basal culture medium, the basal culture medium is DMEM / F12 culture medium, and the additional components are L-glutamine, non-essential amino acids, L-ascorbic acid, sodium selenite, fibronectin, ethanolamine, trypsin inhibitor, human transferrin, coenzyme A, sodium pyruvate and EGF.

[0013] Furthermore, the added ingredients are: L-glutamine at a concentration of 2-3mM, non-essential amino acids at a concentration of 1-1.5mM, L-ascorbic acid at a concentration of 20-30mg / L, sodium selenite at a concentration of 5-12µg / L, fibronectin at a concentration of 20-28mg / L, ethanolamine at a concentration of 2-3mg / L, trypsin inhibitor at a concentration of 1-2mg / L, human transferrin at a concentration of 3-7mg / L, coenzyme A at a concentration of 60-70mg / L, sodium pyruvate at a concentration of 2-4mM, and EGF at a concentration of 10-15µg / L.

[0014] Furthermore, the culture temperature of the culture in step (5) is 35-37°C.

[0015] Furthermore, the pH value of the fresh culture medium is 7.1-7.3, and the osmotic pressure is 250-300mosm.

[0016] Furthermore, the non-essential amino acids are glutamic acid, aspartic acid and glycine in a mass ratio of 1:1.2-1.5:0.4-0.7.

[0017] The present invention also provides the use of the placenta amniotic mesenchymal stem cells obtained by the extraction method in postpartum recovery.

[0018] Compared with the prior art, the advantages and beneficial effects of the present invention are as follows: the present invention provides a method for separating and extracting placental amniotic mesenchymal stem cells. The extraction method and the special extraction culture medium proposed by the present invention can quickly obtain placental amniotic mesenchymal stem cells with less damage to the stem cells. The stem cells are of high purity and have high proliferation and differentiation abilities, and can be used in postpartum recovery. DETAILED DESCRIPTION

[0019] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0020] Example 1 This embodiment provides a method for isolating and extracting placental amniotic mesenchymal stem cells, comprising the following steps: (1) Place the placenta in a processing tray, peel off the amniotic membrane from the placenta along the connection between the umbilical cord and the placenta, wash it twice with cleaning solution, and then rinse it twice with 75% alcohol; (2) Cut the rinsed amniotic membrane into pieces of 1 cm 2 The amniotic tissue was washed twice with a cleaning solution, and the washed amniotic tissue was placed in a test tube and a mixture of type I and II collagenase and phosphate buffer was added, and treated at 35°C for 30 minutes; (3) Continue to wash the treated amniotic tissue twice with cleaning solution, add collagenase I, DNase I and normal saline, and digest at 35°C and 160 rpm for 30 minutes; (4) After shaking digestion, add physiological saline, centrifuge at 1400 rpm at 35°C for 5 minutes, discard the supernatant, and obtain the centrifuged cells; (5) Add the centrifuged cells to fresh culture medium and culture them in a CO2 incubator.

[0021] In step (2), the mass ratio of type I and type II collagenase is 1:1.2.

[0022] In step (2), 1 mL of a mixture of type I and II collagenase and phosphate buffer is used per gram of adipose tissue, and the treatment time is 1 hour.

[0023] In step (3), the concentration of collagenase I in the centrifuge tube is 0.1wt%, and the concentration of DNase I is 0.02wt%.

[0024] The fresh culture medium in step (5) is composed of a basal culture medium and additional components added to the basal culture medium, wherein the basal culture medium is DMEM / F12 culture medium, and the additional components are L-glutamine, non-essential amino acids, L-ascorbic acid, sodium selenite, fibronectin, ethanolamine, trypsin inhibitor, human transferrin, coenzyme A, sodium pyruvate and EGF.

[0025] The added ingredients are: L-glutamine at a concentration of 2 mM, non-essential amino acids at a concentration of 1 mM, L-ascorbic acid at a concentration of 20 mg / L, sodium selenite at a concentration of 5 µg / L, fibronectin at a concentration of 20 mg / L, ethanolamine at a concentration of 2 mg / L, trypsin inhibitor at a concentration of 1 mg / L, human transferrin at a concentration of 3 mg / L, coenzyme A at a concentration of 60 mg / L, sodium pyruvate at a concentration of 2 mM, and EGF at a concentration of 10 µg / L.

[0026] The culture temperature of the culture in step (5) is 35°C.

[0027] The pH of the fresh medium was 7.1 and the osmotic pressure was 250 mosm.

[0028] The non-essential amino acids are glutamic acid, aspartic acid and glycine in a mass ratio of 1:1.2:0.4.

[0029] Example 2 This embodiment provides a method for isolating and extracting placental amniotic mesenchymal stem cells, comprising the following steps: (1) Place the placenta in a processing tray, peel off the amniotic membrane from the placenta along the connection between the umbilical cord and the placenta, wash it 4 times with cleaning solution, and then rinse it 4 times with 75% alcohol by volume; (2) Cut the rinsed amniotic membrane into pieces of 2 cm 2 The amniotic tissue was washed with a cleaning solution for 3 times, and the washed amniotic tissue was placed in a test tube and a mixture of type I and II collagenase and phosphate buffer was added, and treated at 36°C for 40 minutes; (3) Continue to wash the treated amniotic tissue with cleaning solution for 4 times, add collagenase I, DNase I and normal saline, and digest at 36°C and 180 rpm for 40 minutes; (4) After shaking digestion, add physiological saline, centrifuge at 1500 rpm at 36°C for 10 min, discard the supernatant, and obtain the centrifuged cells; (5) Add the centrifuged cells to fresh culture medium and culture them in a CO2 incubator.

[0030] In step (2), the mass ratio of type I and type II collagenase is 1:1.7.

[0031] In step (2), 1 mL of a mixture of type I and II collagenase and phosphate buffer is used per gram of adipose tissue, and the treatment time is 1.5 hours.

[0032] In step (3), the concentration of collagenase I in the centrifuge tube is 0.1wt%, and the concentration of DNase I is 0.02wt%.

[0033] The fresh culture medium in step (5) is composed of a basal culture medium and additional components added to the basal culture medium, wherein the basal culture medium is DMEM / F12 culture medium, and the additional components are L-glutamine, non-essential amino acids, L-ascorbic acid, sodium selenite, fibronectin, ethanolamine, trypsin inhibitor, human transferrin, coenzyme A, sodium pyruvate and EGF.

[0034] The added ingredients are: L-glutamine at a concentration of 3 mM, non-essential amino acids at a concentration of 1.5 mM, L-ascorbic acid at a concentration of 30 mg / L, sodium selenite at a concentration of 12 µg / L, fibronectin at a concentration of 28 mg / L, ethanolamine at a concentration of 3 mg / L, trypsin inhibitor at a concentration of 2 mg / L, human transferrin at a concentration of 7 mg / L, coenzyme A at a concentration of 70 mg / L, sodium pyruvate at a concentration of 4 mM, and EGF at a concentration of 15 µg / L.

[0035] The culture temperature of the culture in step (5) is 37°C.

[0036] The pH of the fresh medium was 7.3 and the osmotic pressure was 300mosm.

[0037] The non-essential amino acids are glutamic acid, aspartic acid and glycine in a mass ratio of 1: 1.5: 0.7.

[0038] Example 3 This embodiment provides a method for isolating and extracting placental amniotic mesenchymal stem cells, comprising the following steps: (1) Place the placenta in a processing tray, peel off the amniotic membrane from the placenta along the connection between the umbilical cord and the placenta, wash it twice with cleaning solution, and then rinse it four times with 75% alcohol; (2) Cut the rinsed amniotic membrane into pieces of 1 cm 2 The amniotic tissue was washed with a cleaning solution for 3 times, and the washed amniotic tissue was placed in a test tube and a mixture of type I and II collagenase and phosphate buffer was added, and the mixture was treated at 35°C for 40 minutes; (3) Continue to wash the treated amniotic tissue twice with cleaning solution, add collagenase I, DNase I and normal saline, and digest at 36°C and 160 rpm for 40 minutes; (4) After shaking digestion, add physiological saline, centrifuge at 1500 rpm at 35°C for 5 minutes, discard the supernatant, and obtain the centrifuged cells; (5) Add the centrifuged cells to fresh culture medium and culture them in a CO2 incubator.

[0039] In step (2), the mass ratio of type I and type II collagenase is 1:1.7.

[0040] In step (2), 1 mL of a mixture of type I and II collagenase and phosphate buffer is used per gram of adipose tissue, and the treatment time is 1 hour.

[0041] In step (3), the concentration of collagenase I in the centrifuge tube is 0.1wt%, and the concentration of DNase I is 0.02wt%.

[0042] The fresh culture medium in step (5) is composed of a basal culture medium and additional components added to the basal culture medium, wherein the basal culture medium is DMEM / F12 culture medium, and the additional components are L-glutamine, non-essential amino acids, L-ascorbic acid, sodium selenite, fibronectin, ethanolamine, trypsin inhibitor, human transferrin, coenzyme A, sodium pyruvate and EGF.

[0043] The added ingredients are: L-glutamine at a concentration of 3 mM, non-essential amino acids at a concentration of 1 mM, L-ascorbic acid at a concentration of 30 mg / L, sodium selenite at a concentration of 5 µg / L, fibronectin at a concentration of 28 mg / L, ethanolamine at a concentration of 2 mg / L, trypsin inhibitor at a concentration of 2 mg / L, human transferrin at a concentration of 3 mg / L, coenzyme A at a concentration of 70 mg / L, sodium pyruvate at a concentration of 2 mM, and EGF at a concentration of 15 µg / L.

[0044] The culture temperature of the culture in step (5) is 35°C.

[0045] The pH of the fresh medium was 7.3 and the osmotic pressure was 250 mosm.

[0046] The non-essential amino acids are glutamic acid, aspartic acid and glycine in a mass ratio of 1: 1.5:0.4.

[0047] Example 4 This embodiment provides a method for isolating and extracting placental amniotic mesenchymal stem cells, comprising the following steps: (1) Place the placenta in a processing tray, peel off the amniotic membrane from the placenta along the connection between the umbilical cord and the placenta, wash it three times with cleaning solution, and then rinse it three times with 75% alcohol by volume; (2) Cut the rinsed amniotic membrane into pieces of 2 cm 2 The amniotic tissue was washed with a cleaning solution for three times, and the washed amniotic tissue was placed in a test tube and a mixture of type I and II collagenase and phosphate buffer was added, and treated at 355°C for 35 minutes; (3) Continue to wash the treated amniotic tissue with cleaning solution for 3 times, add collagenase I, DNase I and normal saline, and digest at 35°C and 170 rpm for 35 minutes; (4) After shaking digestion, add physiological saline, centrifuge at 1460 rpm at 35°C for 8 minutes, discard the supernatant, and obtain the centrifuged cells; (5) Add the centrifuged cells to fresh culture medium and culture them in a CO2 incubator.

[0048] In step (2), the mass ratio of type I and type II collagenase is 1:1.5.

[0049] In step (2), 1 mL of a mixture of type I and II collagenase and phosphate buffer is used per gram of adipose tissue, and the treatment time is 1.3 hours.

[0050] In step (3), the concentration of collagenase I in the centrifuge tube is 0.1wt%, and the concentration of DNase I is 0.02wt%.

[0051] The fresh culture medium in step (5) is composed of a basal culture medium and additional components added to the basal culture medium, wherein the basal culture medium is DMEM / F12 culture medium, and the additional components are L-glutamine, non-essential amino acids, L-ascorbic acid, sodium selenite, fibronectin, ethanolamine, trypsin inhibitor, human transferrin, coenzyme A, sodium pyruvate and EGF.

[0052] The added ingredients are: L-glutamine at a concentration of 2.5 mM, non-essential amino acids at a concentration of 1.2 mM, L-ascorbic acid at a concentration of 23 mg / L, sodium selenite at a concentration of 8 µg / L, fibronectin at a concentration of 24 mg / L, ethanolamine at a concentration of 2.5 mg / L, trypsin inhibitor at a concentration of 1.5 mg / L, human transferrin at a concentration of 5 mg / L, coenzyme A at a concentration of 65 mg / L, sodium pyruvate at a concentration of 3 mM, and EGF at a concentration of 12 µg / L.

[0053] The culture temperature of the culture in step (5) is 36°C.

[0054] The pH of the fresh medium was 7.2 and the osmotic pressure was 270 mosm.

[0055] The non-essential amino acids are glutamic acid, aspartic acid and glycine in a mass ratio of 1:1.4:0.6.

[0056] Example 5 This embodiment provides a method for isolating and extracting placental amniotic mesenchymal stem cells, comprising the following steps: (1) Place the placenta in a processing tray, peel off the amniotic membrane from the placenta along the connection between the umbilical cord and the placenta, wash it twice with cleaning solution, and then rinse it twice with 75% alcohol by volume; (2) Cut the rinsed amniotic membrane into pieces of 1 cm 2 The amniotic tissue was washed twice with a cleaning solution, and the washed amniotic tissue was placed in a test tube and a mixture of type I and II collagenase and phosphate buffer was added, and the mixture was treated at 35°C for 30 minutes; (3) Continue to wash the treated amniotic tissue twice with cleaning solution, add collagenase I, DNase I and normal saline, and digest at 35°C and 160 rpm for 30 minutes; (4) After shaking digestion, add physiological saline, centrifuge at 1400 rpm at 35°C for 5 minutes, discard the supernatant, and obtain the centrifuged cells; (5) Add the centrifuged cells to fresh culture medium and culture them in a CO2 incubator.

[0057] In step (2), the mass ratio of type I and type II collagenase is 1:1.2.

[0058] In step (2), 1 mL of a mixture of type I and II collagenase and phosphate buffer is used per gram of adipose tissue, and the treatment time is 1 hour.

[0059] In step (3), the concentration of collagenase I in the centrifuge tube is 0.1wt%, and the concentration of DNase I is 0.02wt%.

[0060] The fresh culture medium in step (5) is composed of a basal culture medium and additional components added to the basal culture medium, wherein the basal culture medium is DMEM / F12 culture medium, and the additional components are L-glutamine, non-essential amino acids, L-ascorbic acid, sodium selenite, fibronectin, ethanolamine, trypsin inhibitor, human transferrin, coenzyme A, sodium pyruvate and EGF.

[0061] The added ingredients are: L-glutamine at a concentration of 2.2 mM, non-essential amino acids at a concentration of 1.1 mM, L-ascorbic acid at a concentration of 22 mg / L, sodium selenite at a concentration of 6 µg / L, fibronectin at a concentration of 22 mg / L, ethanolamine at a concentration of 2.1 mg / L, trypsin inhibitor at a concentration of 1.4 mg / L, human transferrin at a concentration of 3.4 mg / L, coenzyme A at a concentration of 65 mg / L, sodium pyruvate at a concentration of 2.4 mM, and EGF at a concentration of 11 µg / L.

[0062] The culture temperature of the culture in step (5) is 35°C.

[0063] The pH of the fresh medium was 7.1 and the osmotic pressure was 250 mosm.

[0064] The non-essential amino acids are glutamic acid, aspartic acid and glycine in a mass ratio of 1:1.2:0.4.

[0065] Example 6 This embodiment provides a method for isolating and extracting placental amniotic mesenchymal stem cells, comprising the following steps: (1) Place the placenta in a processing tray, peel off the amniotic membrane from the placenta along the connection between the umbilical cord and the placenta, wash it twice with cleaning solution, and then rinse it twice with 75% alcohol by volume; (2) Cut the rinsed amniotic membrane into pieces of 1 cm 2The amniotic tissue was washed twice with a cleaning solution, and the washed amniotic tissue was placed in a test tube and a mixture of type I and II collagenase and phosphate buffer was added, and treated at 35°C for 30 minutes; (3) Continue to wash the treated amniotic tissue twice with cleaning solution, add collagenase I, DNase I and normal saline, and digest at 35°C and 160 rpm for 30 minutes; (4) After shaking digestion, add physiological saline, centrifuge at 1400 rpm at 35°C for 5 minutes, discard the supernatant, and obtain the centrifuged cells; (5) Add the centrifuged cells to fresh culture medium and culture them in a CO2 incubator.

[0066] In step (2), the mass ratio of type I and type II collagenase is 1:1.2.

[0067] In step (2), 1 mL of a mixture of type I and II collagenase and phosphate buffer is used per gram of adipose tissue, and the treatment time is 1 hour.

[0068] In step (3), the concentration of collagenase I in the centrifuge tube is 0.1wt%, and the concentration of DNase I is 0.02wt%.

[0069] The fresh culture medium in step (5) is composed of a basal culture medium and additional components added to the basal culture medium, wherein the basal culture medium is DMEM / F12 culture medium, and the additional components are L-glutamine, non-essential amino acids, L-ascorbic acid, sodium selenite, fibronectin, ethanolamine, trypsin inhibitor, human transferrin, coenzyme A, sodium pyruvate and EGF.

[0070] The added ingredients are: L-glutamine at a concentration of 2.8 mM, non-essential amino acids at a concentration of 1.4 mM, L-ascorbic acid at a concentration of 27 mg / L, sodium selenite at a concentration of 9 µg / L, fibronectin at a concentration of 26 mg / L, ethanolamine at a concentration of 2.6 mg / L, trypsin inhibitor at a concentration of 1.8 mg / L, human transferrin at a concentration of 6 mg / L, coenzyme A at a concentration of 68 mg / L, sodium pyruvate at a concentration of 3.8 mM, and EGF at a concentration of 14 µg / L.

[0071] The culture temperature of the culture in step (5) is 35°C.

[0072] The pH of the fresh medium was 7.1 and the osmotic pressure was 250 mosm.

[0073] The non-essential amino acids are glutamic acid, aspartic acid and glycine in a mass ratio of 1:1.2:0.4.

[0074] The extraction method of the above embodiment can quickly obtain placental amniotic mesenchymal stem cells. The stem cells are of high purity, have high proliferation and differentiation abilities, and have good effects when applied to postpartum recovery. The method of the present invention has extremely high market value and broad application prospects.

[0075] The above is a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A method for isolating and extracting placental amniotic mesenchymal stem cells, characterized in that: The following steps are involved: (1) Place the placenta in a processing tray, peel off the amniotic membrane from the placenta along the connection between the umbilical cord and the placenta, wash it with cleaning solution 2-4 times, and then rinse it with 75% alcohol by volume 2-4 times; (2) Cut the rinsed amniotic membrane into pieces of 1-2 cm 2 The amniotic tissue is washed with a cleaning solution for 2-3 times, and the washed amniotic tissue is placed in a test tube and a mixture of type I and II collagenase and phosphate buffer is added, and the mixture is treated at 35-36°C for 30-40 minutes; (3) Continue to wash the treated amniotic tissue with cleaning solution for 2-4 times, add collagenase I, DNase I and normal saline, and digest at 35-36°C and 160-180 rpm for 30-40 minutes; (4) After shaking digestion, add physiological saline, centrifuge at 1400-1500 rpm at 35-36°C for 5-10 minutes, discard the supernatant, and obtain the centrifuged cells; (5) Add the centrifuged cells to fresh culture medium and culture them in a CO2 incubator.

2. The method for isolating and extracting placental amniotic mesenchymal stem cells according to claim 1, characterized in that: In step (2), the mass ratio of type I to type II collagenase is 1:1.2-1.

7.

3. The method for isolating and extracting placental amniotic mesenchymal stem cells according to claim 1, characterized in that: In step (2), 1 mL of a mixture of type I and II collagenase and phosphate buffer is used per gram of adipose tissue, and the treatment time is 1-1.5 hours.

4. The method for isolating and extracting placental amniotic mesenchymal stem cells according to claim 1, characterized in that: In step (3), the concentration of collagenase I in the centrifuge tube is 0.1wt%, and the concentration of DNase I is 0.02wt%.

5. The method for isolating and extracting placental amniotic mesenchymal stem cells according to claim 1, characterized in that: The fresh culture medium in step (5) is composed of a basal culture medium and additional components added to the basal culture medium, wherein the basal culture medium is DMEM / F12 culture medium, and the additional components are L-glutamine, non-essential amino acids, L-ascorbic acid, sodium selenite, fibronectin, ethanolamine, trypsin inhibitor, human transferrin, coenzyme A, sodium pyruvate and EGF.

6. The method for isolating and extracting placental amniotic mesenchymal stem cells according to claim 5, characterized in that: The added ingredients are: L-glutamine at a concentration of 2-3mM, non-essential amino acids at a concentration of 1-1.5mM, L-ascorbic acid at a concentration of 20-30mg / L, sodium selenite at a concentration of 5-12µg / L, fibronectin at a concentration of 20-28mg / L, ethanolamine at a concentration of 2-3mg / L, trypsin inhibitor at a concentration of 1-2mg / L, human transferrin at a concentration of 3-7mg / L, coenzyme A at a concentration of 60-70mg / L, sodium pyruvate at a concentration of 2-4mM, and EGF at a concentration of 10-15µg / L.

7. The method for isolating and extracting placental amniotic mesenchymal stem cells according to claim 1, characterized in that: The culture temperature of the culture in step (5) is 35-37°C.

8. The method for isolating and extracting placental amniotic mesenchymal stem cells according to claim 1, characterized in that: The pH of the fresh medium is 7.1-7.3 and the osmotic pressure is 250-300mosm.

9. The method for isolating and extracting placental amniotic mesenchymal stem cells according to claim 6, characterized in that: The non-essential amino acids are glutamic acid, aspartic acid and glycine in a mass ratio of 1:1.2-1.5:0.4-0.

7.

10. Use of placental amniotic mesenchymal stem cells obtained by the extraction method according to any one of claims 1 to 9 in postpartum recovery.